Spotex by is a Prescription medication manufactured, distributed, or labeled by Pella Pharmaceuticals Co. Ltd. Drug facts, warnings, and ingredients follow.
Erythromycin which belongs to a class of chemicals called macrolide antibiotics; exerts its antibacterial action by binding to the 50S ribosomal subunit of susceptible bacteria and suppressing protein synthesis. Erythromycin is usually bacteriostatic but may be bactericidal in high concentrations or against highly susceptible organisms.
If you use
Spotex on your face don t get it in your eyes, nose/nostrils, mouth, or on your lips. If you do, wash the area with large amount of warm water. And do not use
Spotex on areas where you have cuts or scrapes.
Excessive exposure to sunlight or ultraviolet rays ( sun lamps) should be avoided during treatment with Spotex because the additional irradiation may lead to a more intense action.
If sunburn occurs, it is advisable to interrupt therapy until the severe erythema and peeling subside. Patients whose occupations require considerable exposure to the sun should exercise particular caution.
Do not use
Spotex with any other acne products that are used on the skin unless your doctor or pharmacist has told you that you can.
While you are using Spotex, do not use skin cleansers that remove dead skin (these are called exfoliants), medicated soaps or cosmetics containing alcohol. These could make your skin irritated or dry.
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
Topical gels and creams are intended for external use only and should be kept away from eyes, nose, mouth, and other mucous membranes because of its irritant effect. Do not apply to eyelids or to the skin at the corners of the eyes and mouth. Avoid the angles of the nose and nasolabial fold (if treatment in these areas; is necessary, apply very sparingly). Topical use may induce severe local erythema and peeling at the site of application. If the degree of local irritation warrants, patients should be directed to use the medication less frequently, discontinue use temporarily or discontinue use altogether.
Spotex once in the morning and once in the evening, unless your doctor or pharmacist has told you otherwise.
Wash the affected areas with water or with a mild cleanser, and then thoroughly dry the affected areas and gently apply on a thin film of Spotex using the tips of your fingers. Don't forget to wash your hands afterwards.
The alcohol quickly evaporates and erythrornycin penetrates into your skin without leaving an unpleasant film, after you have used Spotex; screw the cap tightly on the tube.
How long you will have to use Spotex will depend on how quickly your acne improves. You may well use Spotex Gel for one month and then a lower strength product for one more month. Your doctor will decide which strength to prescribe for you.
It is recommended to use sunscreens over treated areas before sun exposure.
Do not put too much
Spotex on your skin. You will not get rid of the acne any quicker. If you put on too much, your skin may become irritated and red. Some peeling or discomfort could also occur. If any of these happen, use
Spotex once a day in the evening until they have gone. Then apply
Spotex twice a day as you did previously. If the effects continue or are causing you a lot of discomfort, stop using the product and ask your doctor or pharmacist for advice.
In the rare event that you accidentally swallow any of this product, seek medical advice.
Like all medicines
Spotex can cause side effects, although not everybody gets them. These might include dryness, itching, redness, peeling or oiliness. You might feel a stinging or burning sensation when you put it on your skin. Usually the effects are not serious and happen at the start of treatment. More often than not, they go away as you continue to use the gel.
If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
|Labeler - Pella Pharmaceuticals Co. Ltd (562370925)|